Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Expert Opin Drug Discov. 2012 Jul 19;7(9):831–847. doi: 10.1517/17460441.2012.708335

Figure 4. Chelation therapy agents with reported antibacterial activity.

Figure 4

Ciclopirox 8, deferiprone 9 and deferasirox 10 are three FDA-approved chelation therapy agents that have been investigated for their antifungal activities.